SEC Filings

Form 4 AMPHENOL CORP /DE/ For: May 17 Filed by: Altobello Nancy A. May 21, 2024 09:56AM

http://archive.fast-edgar.com/20240521/APZ2T22CSC2252TU222N22Z2BP3N2228Z262

Filed on: May 21, 2024

Form 424B2 JPMORGAN CHASE & CO May 21, 2024 09:56AM

http://archive.fast-edgar.com/20240521/AQ22822CLZ22Q94L229L2ZY2ACF82222Z262

Filed on: May 21, 2024

Form 8-K OLD SECOND BANCORP INC For: May 21 May 21, 2024 09:55AM OLD SECOND BANCORP INC0000357173false00003571732024-05-212024-05-21

​

I

​

United States

Securities And Exchange CommissionWashington, D.C. 20549

​

FORM 8-K

​

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 21, 2024

(Exact name of registrant as specified in its charter)

​

​

​

Delaware

000-10537

36-3143493

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer... (continue reading...)

Form PX14A6G COMCAST CORP Filed by: National Legal & Policy Center May 21, 2024 09:55AM

United States Securities and Exchange Commission

Washington, D.C. 20549

 

 

NOTICE OF EXEMPT SOLICITATIONPursuant to Rule 14a-103

 

Name of the Registrant: Comcast Corporation

Name of persons relying on exemption: National Legal and Policy Center

Address of persons relying on exemption: 107 Park Washington Court, Falls Church, VA 22046

 

Written materials are submitted pursuant to Rule 14a-6(g) (1) promulgated under the Securities Exchange Act of 1934. Submission is... (continue reading...)

Form 424B2 CITIGROUP INC May 21, 2024 09:55AM

 

The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, prospectus supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in any state where the offer or sale is not... (continue reading...)